Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FOUND: Clov | Mind Blowing Facts

Clover Beats Q2 Estimates, Stock Drops: Here Are The Details

Healthcare technology company Clover Health Investments Corp. (NASDAQ:CLOV) is trading lower after reporting second-quarter financial results after market close on Tuesday.

Benzinga

What's Going On With Clover Health Stock?

Clover Health Investments, Corp. (NASDAQ:CLOV) stock is trading 5% higher on Tuesday, adding to gains of more than 12% over the past week. Here’s a look at some key highlights.

Benzinga

The Saturday Spread: KR, CAT and CLOV Show a Statistical Edge for Bullish Traders This Week

Conditional probability modeling shows potentially compelling opportunities in these three stocks to buy.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Clover Health (CLOV) vs. Elevance Health (ELV): Buy, Hold, or Sell in 2024

The medical sector’s prospects look attractive with increasing global demand for quality healthcare services and technological advances in healthcare systems. So, let’s analyze the fundamentals of medical stocks Clover Health Investments (CLOV) and Elevance Health (ELV).

StockNews.com

3 Medical Stocks to Add to Your September Watchlist

The medical industry is growing as demand for healthcare products and services rises amid the growing incidence of chronic diseases and an aging population. Therefore, I think medical stocks HealthEquity (HQY), Clover Health Investments (CLOV), and Oscar Health (OSCR) might be worth adding to one’s watchlist. Read on.

StockNews.com

Clover Health Investments (CLOV) vs. Cigna (CI): Which Medical Stock is the Bigger Buy?

The ever-rising healthcare costs are boosting the insurance industry in the current economic landscape. While prominent industry players Clover Health (CLOV) and Cigna Group (CI) should benefit, let us analyze which is the bigger buy.

StockNews.com

Buy, Sell or Hold: What Should Investors Do With Clover Health Investments (CLOV)?

While medicare provider Clover Health (CLOV) seems optimistic about its prospects, Street analysts expect its revenue to decline in the coming quarters. So, should you Buy, Sell or Hold the stock now? Keep reading.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Clover Health Investments (CLOV): Buy, Hold or Sell End of June?

Clover Health (CLOV) has been subject to several lawsuits and federal investigations. Also, the company’s bottom line is in the red. However, CLOV is ramping up its efforts to accelerate its path to profitability. So, should you Buy, Hold or Sell the stock now? Read on to learn my views.

StockNews.com

Clover Health Investments (CLOV) vs. Molina Healthcare (MOH): Which Stock Has Healthier Returns?

Rising medical requirements and simultaneous soaring medical costs have enhanced the need for healthcare insurance. Given this backdrop, let’s compare health insurance stocks Molina Healthcare (MOH) and Clover Health Investments (CLOV) to discover which of these stocks is a better buy now. Read on….

StockNews.com

A Look Into Clover Health (CLOV) and Humana (HUM): Are They Worth Investing In?

The medical industry thrives due to rising demand for healthcare products and services, fueling significant growth. Therefore, quality medical stock Humana (HUM) could be worth buying. However, considering its weak fundamentals, I think it will be best to wait for a better entry point in Clover Health Investments (CLOV). Read…

StockNews.com

2 Health Insurance Stocks to Buy in October and 1 to Avoid

The raging inflation is expected to increase healthcare expenditure significantly. This, along with heightened health awareness in this post-pandemic era, should drive the demand for health insurance. So, investing in fundamentally strong health insurance stocks, UnitedHealth Group (UNH) and Humana Inc. (HUM), could be wise. On the other hand, Clover…

StockNews.com

Billionaire VC Chamath Palihapitiya Sells Clover Health Shares: Is He No Longer Bullish?

Once touted as the SPAC King, Chamath Palihapitiya used blank check companies to take several private companies public. But as the SPAC craze dies out, the billionaire venture capitalist is now distancing himself from those particular investment vehicles.

Benzinga

3 SPAC Stocks Down More Than 60% Since Going Public

The Federal Reserve's interest rate increases to reduce inflationary pressure, and recession fears, have driven many SPAC stocks to significant price declines of late. The shares of Hims & Hers Health (HIMS), Clover Health Investments (CLOV), and BARK (BARK) have retreated more than 60% since these companies went public via…

StockNews.com

Better Buy for 2022: Clover Health vs. Centene

The COVID-19 pandemic has been a blessing for the healthcare plan industry due to increased healthcare spending. In addition, with the rising healthcare needs of an aging population, the industry’s prospects look bright. Clover Health Investments, Corp. (CLOV) and Centene (CNC) should benefit from this trend. But which of these…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why Did Chelsea Clinton Buy Shares Of This Healthcare Company?

Clover Health Investments Corp (NASDAQ: CLOV) shares are surging Monday following insider buying from a prominent public figure.

StockNews.com

Forget Clover, Buy These 4 Healthcare Plan Stocks Instead

The pandemic-driven increase in health awareness and rising chronic diseases should drive the healthcare-plans industry’s growth. However, not all industry participants are well-positioned to gain in the near term. Clover Health (CLOV), with inconsistent financials and growth, is not expected to perform well. Therefore, fundamentally sound stocks in this space—UnitedHealth…

Benzinga

Why Clover Health Shares Are Surging After Hours

Clover Health Investments Corp (NASDAQ: CLOV) is ripping higher in Wednesday's after-hours session after the company released its fourth-quarter financial results.

Benzinga

Thinking About Buying Stock In Clover Health, Jumia Or Lemonade?

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers and following industry trends.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Clover Health vs. Anthem: Which Healthcare Plan Stock is a Better Buy?

An aging population and rising healthcare spending have been driving the growth of the healthcare plans industry. Therefore, both Anthem (ANTM) and Clover (CLOV) should see an increase in demand for their products. But which one of these stocks is a better buy right now? Read on.

StockNews.com

Better Buy for 2022: Humana vs. Clover Health

The rising aging population and the increasing spending on healthcare have been driving the health insurance industry’s growth. So, Humana (HUM) and Clover (CLOV) should benefit. But which of these two stocks is a better buy now? Read more to find out.

Benzinga

Expert Ratings For Clover Health Investments

Within the last quarter, Clover Health Investments (NASDAQ:CLOV) has observed the following analyst ratings:

People

Kritika SarmahHer

727 stories

Dipanjan BanchurSince

722 stories

Steve Reitmeister

508 stories

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.